Zura Bio Ltd
Financial highlights
| Metric | FY December 31, 2025 | FY December 31, 2024 | FY December 31, 2023 | FY December 31, 2022 | FY December 31, 2021 |
|---|---|---|---|---|---|
| Operating income | -$75.2M | -$55.2M | -$62.6M | -$27.2M | — |
| Operating expenses | $75.2M | $55.2M | $62.6M | $27.2M | — |
| Cash from operations | -$64.8M | -$28.1M | -$15.1M | -$1.2M | — |
| Capital expenditure | $113,000 | $75,000 | — | — | — |
| Free cash flow | -$64.9M | -$28.2M | — | — | — |
| Total assets | $113.9M | $179.5M | $100.8M | $5.3M | $140.6M |
| Total liabilities | $12.4M | $19.5M | $21.3M | $14.8M | $10.4M |
Shares outstanding 95.0M · Free float 61.7%
Annual filing data through FY ended December 31, 2025; float as of June 27, 2026.